Literature DB >> 9461353

Long-term outcome for non-handicapped low birth weight infants--is the fog clearing?

K Sommerfelt1.   

Abstract

The frequency of cerebral palsy increases with decreasing gestational age affecting approximately 7% of survivors with birth weights less than 1500 g (very low birth weight, VLBW) [7]. In addition, low birth weight (birth weight less than 2500 g, LBW) and VLBW children without cerebral palsy or other major neurohandicaps have an increased frequency of "new morbidities" including learning disabilities, behavioural problems, lower mean IQ, and motor clumsiness compared to normal birth weight peers [15, 16, 20]. However, understanding is still lacking regarding the nature and frequency of such problems, predisposing risk factors, and the relationship of such problems with parental factors, including socio-economic status. A fundamental concept for understanding the large and often confusing literature on LBW and later neurobehavioral development is that LBW may have many different aetiologies, with varying relative frequency in different populations, which probably have different degrees of associated risk for impairment of later development.

Entities:  

Mesh:

Year:  1998        PMID: 9461353     DOI: 10.1007/s004310050755

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  3 in total

1.  Long-term behavioral assessment of guinea pigs following neonatal pneumoperitoneum.

Authors:  E Fuh; S de la Fuente; M K Shah; D K Okodiko; T J Cummings; W S Eubanks; J D Reynolds
Journal:  Surg Endosc       Date:  2005-03-11       Impact factor: 4.584

2.  Early postnatal behavior deficits after maternal carbon dioxide pneumoperitoneum during pregnancy.

Authors:  S G de la Fuente; J Pinheiro; M Gupta; W S Eubanks; J D Reynolds
Journal:  Surg Endosc       Date:  2003-06-17       Impact factor: 4.584

3.  Concordance between school outcomes and developmental follow-up results of very preterm and/or low birth weight children at the age of 5 years.

Authors:  Boudien van Kessel-Feddema; Meta Sondaar; Martin de Kleine; Christianne Verhaak; Anneloes van Baar
Journal:  Eur J Pediatr       Date:  2006-11-16       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.